First Time Loading...

Abcellera Biologics Inc
NASDAQ:ABCL

Watchlist Manager
Abcellera Biologics Inc Logo
Abcellera Biologics Inc
NASDAQ:ABCL
Watchlist
Price: 4.11 USD 1.99% Market Closed
Updated: May 7, 2024
ABCL
/
Income Statement
/
Revenue

Abcellera Biologics Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Abcellera Biologics Inc
Revenue Peer Comparison

Comparables:
ARCH
RP
IOT

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Abcellera Biologics Inc
NASDAQ:ABCL
Revenue
$38m
CAGR 3-Years
-45%
CAGR 5-Years
34%
CAGR 10-Years
N/A
Arch Biopartners Inc
XTSX:ARCH
Revenue
CA$4.9m
CAGR 3-Years
239%
CAGR 5-Years
N/A
CAGR 10-Years
62%
Replicel Life Sciences Inc
XTSX:RP
Revenue
CA$353.7k
CAGR 3-Years
-5%
CAGR 5-Years
N/A
CAGR 10-Years
-22%
Innovotech Inc
XTSX:IOT
Revenue
CA$1.1m
CAGR 3-Years
2%
CAGR 5-Years
6%
CAGR 10-Years
2%

Abcellera Biologics Inc
Revenue Breakdown

Breakdown by Geography
Abcellera Biologics Inc

Total Revenue: 38m USD
100%
Canada: 36m USD
94.7%
United States: 2m USD
5.3%

Breakdown by Segments
Abcellera Biologics Inc

Total Revenue: 38m USD
100%
Research Fees: 35.6m USD
93.5%
Milestone Payments: 1.5m USD
3.9%
Licensing Revenue: 969k USD
2.5%

See Also

What is Abcellera Biologics Inc's Revenue?
Revenue
38m USD

Based on the financial report for Dec 31, 2023, Abcellera Biologics Inc's Revenue amounts to 38m USD.

What is Abcellera Biologics Inc's Revenue growth rate?
Revenue CAGR 5Y
34%

Over the last year, the Revenue growth was -92%. The average annual Revenue growth rates for Abcellera Biologics Inc have been -45% over the past three years , 34% over the past five years .

ALPHA SPREAD
Join more than 134,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.